arrow
A

Antonio Tavoni

Universita degli Studi di Bari Aldo Moro
H指数:32
被引数:4,010

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comment on: Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study: reply

评论:西利昔帕在系统性硬化症相关指端溃疡中的长期效果:一项病例对照多中心观察性研究:回复

2026-02-010
PRE
Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study

塞来昔帕对系统性硬化症相关指/趾溃疡的长期疗效:一项病例对照多中心观察性研究

2025-07-010
PRE
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity
2023-02-161
OAAI
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases
2022-07-0114
OA
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
2021-12-0194
OA
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study
2021-03-0126
OAAI
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)

利妥昔单抗CT-P10生物仿制药治疗冷球蛋白血症血管炎的安全性和有效性: MARBLe研究 (混合性冷球蛋白血症利妥昔单抗生物仿制药)

2020-06-1011
OAAI
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study
2015-09-0130
OAAI
CRYOGLOBULINEMIC VASCULITIS AND PRIMARY SJOGREN'S SYNDROME ARE INDEPENDENT RISK FACTORS FOR LYMPHOMA IN A LARGE WORLDWIDE POPULATION OF PATIENTS WITH POSITIVE SERUM CRYOGLOBULINS
2015-06-010
PREAI
RITUXIMAB MONOTHERAPY OF SEVERE HCV-RELATED CRYOGLOBULINEMIC VASCULITIS FOR MORE THAN 2 YEARS: FOLLOW-UP OF A RANDOMIZED CONTROLLED MULTICENTRE STUDY
2014-06-010
PREAI